DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Clinical Chemistry, Molecular Diagnostics, Coagulation, Microbiology), By End User, And Segment Forecasts, 2013 - 2022" report has been added to ResearchAndMarkets.com's offering.
The global in vitro diagnostics (IVD) market size is expected to reach USD 97.01 billion by 2022, rising at a CAGR of 6.8% during the forecast period.
Increasing incidence of sexually transmitted and gastrointestinal diseases coupled with surging demand for large-scale screening, particularly for cancer, is stimulating the growth of the market. IVD helps in detecting whether a particular medicine or treatment would work on a patient.
Constant innovations and advancements play a pivotal role in the development of the market. IVD is being increasingly used in every stage of the patient care and nearly each healthcare setting. Though, most of these tests are remotely performed, making their presence unnoticed.
Various organizations are functioning to monitor the market. For instance, BIVDA is an association of companies with high involvement and interest and represents manufacturers and distributors functioning in the U.K.
Rapidly changing healthcare environment and growing acknowledgment of diagnostics role in patient care, along with rising awareness regarding importance of early diagnosis of chronic diseases, are likely to boost the growth of the IVD market.
Surging demand for point-of-care detection and identification of various infectious diseases such respiratory tract infections, including Legionnaires' disease, RSV, influenza, and pneumonia, coupled with pathogens causing filariasis and malaria, is providing a significant push to the market.
Key Topics Covered:
Chapter 1. Executive Summary
Chapter 2. IVD Industry Outlook
Chapter 3. IVD Product Outlook
Chapter 4. IVD Regional Outlook
Chapter 5. Competitive Landscape
Chapter 6. Methodology and Scope
Companies Mentioned
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthcare
- Johnson and Johnson
- Bio-Rad Laboratories
- Beckman Coulter Inc.
- Becton Dickinson
- bioMerieux
- Sysmex
- Bayer Healthcare
- Alere Inc.
- Danaher Corporation
- Hologic (Gen-Probe)
- Novartis
- Cepheid
- Qiagen
- Leica Biosystems
- Dako
For more information about this report visit https://www.researchandmarkets.com/research/smnt24/global_invitro?w=4
